7 unknown. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Unknown 7 |
Follow Cystic Fibrosis: new trials by email Literature Review of Cystic Fibrosis trials Research Report on Cystic Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis Ceftolozane/tazobactam - Bronchiectasis, Cystic Fibrosis | Phase 4 | Unknown | Sunshine Coast Hospital and Health Service | 30 | 2023-10-01 | 2023-09-13 |
| CPET in CF Patients With One G551D Mutation Taking VX770 ivacaftor, placebo - Cystic Fibrosis | Phase 4 | Unknown | The Alfred | 20 | 2014-02-01 | 2016-07-25 |
| Impact of Immunonutrition on the Patients With Cystic Fibrosis Impact-Nutridrink, Nutridrink-Impact - Cystic Fibrosis, Malnutrition | Phase 4 | Unknown | University Hospital, Motol | 30 | 2013-09-01 | 2014-01-29 |
| A Study Comparing Continuous Infusion Antibiotics to Standard Treatment for Lung Infections in Cystic Fibrosis Intermittent, short infusion Ceftazidime, Continuous infusion Ceftazidime, Intermittent, short infusion Meropenem - Cystic Fibrosis | Phase 4 | Unknown | The Alfred | 50 | 2012-09-01 | 2017-04-20 |
| Effect of Azithromycin on Fatty Acids in CF Azithromycin - Cystic Fibrosis | Phase 4 | Unknown | University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn) | 20 | 2012-03-01 | 2018-08-02 |
| Evaluation and Reconditioning of Marginal Lung Donors to Transplantation by ex Vivo Lung Perfusion Ex vivo lung transplantation - Respiratory Tract Diseases | Phase 4 | Unknown | InCor Heart Institute | 20 | 2011-08-01 | 2011-05-12 |
| Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis Ceftazidime, Tobramycin, Meropenem - Cystic Fibrosis | Phase 4 | Unknown | Imperial College London | 240 | 2010-01-01 | 2010-04-13 |
Bronchiectasis (1) · Burkholderia Infections (1) · Malnutrition (1) · Pseudomonas Infections (1) · Pulmonary Disease, Chronic Obstructive (1) · Pulmonary Fibrosis (1) · Respiratory Tract Diseases (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Digestive System Diseases (7) · Genetic Diseases, Inborn (7) · Infant, Newborn, Diseases (7) · Lung Diseases (7) · Pancreatic Diseases (7) · Respiratory Tract Diseases (6) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Bronchial Diseases (1) · Chronic Disease (1) · Disease Attributes (1) · Fibrosis (1) · Gram-Negative Bacterial Infections (1) · Infections (1)
Azithromycin (1) · Ceftazidime (1) · Meropenem (1) · Tobramycin (1) · ceftolozane, tazobactam drug combination (1) · ivacaftor (1)
The Alfred (2) · Imperial College London (1) · InCor Heart Institute (1) · Sunshine Coast Hospital and Health Service (1) · University Childrens' Hospital (Zentrum für Kinderheilkunde des Universitätsklinikum Bonn) (1) · University Hospital, Motol (1)
Australia (2) · Brazil (1) · Czechia (1) · United Kingdom (1)
Andrew Burke, MBBS (1) · Anton Peleg, MBBS, FRACP. (1) · Fabio B Jatene, PhD (1) · Jiri Charvat, MD (1) · John Wilson (1) · Julia J Bashford, BSc, MBBS (1) · Margaret Hodson, MD FRCP DA (1) · Milan Kvapil, MD (1) · Ondrej Hloch, MD (1)